The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi
Martinez, J., Patkaniowska, A., Urlaub, H., Lührmann, R., & Tuschl, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00908-x · Cited by 1,459
RNA interference targeting Fas protects mice from fulminant hepatitis
Song, E., Lee, S.-K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,110
Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B. J., & Yarden, Y. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5276 · Cited by 1,036
siRNA-mediated gene silencing in vitro and in vivo
Xia, H., Mao, Q., Paulson, H. L., & Davidson, B. L. (2002) · Nature Biotechnology · doi:10.1038/nbt739 · Cited by 873
Modulation of HIV-1 replication by RNA interference
Jacque, J.-M., Triques, K., & Stevenson, M. (2002) · Nature · doi:10.1038/nature00896 · Cited by 719
Inhibition of hepatitis B virus in mice by RNA interference
McCaffrey, A. P., Nakai, H., Pandey, K., Huang, Z., Salazar, F. H., Xu, H., Wieland, S. F., Marion, P. L., & Kay, M. A. (2003) · Nature Biotechnology · doi:10.1038/nbt824 · Cited by 607
Bookman, M. A., Darcy, K. M., Clarke-Pearson, D., Boothby, R. A., & Horowitz, I. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.104 · Cited by 598
Coburn, G. A., & Cullen, B. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9225-9231.2002 · Cited by 413
Interference of hepatitis C virus RNA replication by short interfering RNAs
Kapadia, S. B., Brideau-Andersen, A., & Chisari, F. V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252783999 · Cited by 392
A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics
Takei, Y., Kadomatsu, K., Yuzawa, Y., Matsuo, S., & Muramatsu, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2682 · Cited by 378
Trastuzumab: A Review of its Use in the Treatment of Metastatic Breast Cancer Overexpressing HER2
McKeage, K., & Perry, C. M. (2002) · Drugs · doi:10.2165/00003495-200262010-00008 · Cited by 289
Gene transfer with modified polyethylenimines
Kichler, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.507 · Cited by 265
Filleur, S., Courtin, A., Ait‐Si‐Ali, S., Guglielmi, J., Arnold, C., Harel‐Bellan, A., Clézardin, P., & Cabon, F. (2003) · PubMed · Cited by 253
Choudhury, A., Charo, J., Parapuram, S. K., Hunt, R. C., Hunt, D. M., Seliger, B., & Kiessling, R. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.11497 · Cited by 139
Zhang, L., Yang, N., Mohamed-Hadley, A. A., Rubin, S. C., & Coukos, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00495-9 · Cited by 121
Yang, G. S., Cai, K. Q., Thompson-Lanza, J. A., Bast, R. C., & Liu, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311153200 · Cited by 120
Aigner, A. M., Fischer, D., Merdan, T., Brus, C., Kissel, T., & Czubayko, F. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301839 · Cited by 99
Self-citationEffective polyethylenimine‐mediated gene transfer into human endothelial cells
Zaric, V., Weltin, D., Erbacher, P., Rémy, J.-S., Behr, J., & Stéphan, D. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.484 · Cited by 76
Aigner, A. M., Butscheid, M., Kunkel, P., Krause, E., Lamszus, K., Wellstein, A., & Czubayko, F. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010515)92:4<510::aid-ijc1227>3.0.co;2-h · Cited by 73
Self-citationHER-2/neu Is Rate-limiting for Ovarian Cancer Growth
Juhl, H. H., Downing, S. G., Wellstein, A., & Czubayko, F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29482 · Cited by 70
Self-citationTargeted nucleic acid delivery into tumors: new avenues for cancer therapy
Wagner, E., Kircheis, R., & Walker, G. F. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.003 · Cited by 68
Dheur, S., Dias, N., Aerschot, A. A. V., Herdewijn, P. A., Bettinger, T., Rémy, J.-S., Hélène, C., & Saison-Behmoaras, E. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.515 · Cited by 64
Aigner, A. M., Ray, P. E., Czubayko, F., & Wellstein, A. (2001) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0360-4 · Cited by 45
Self-citationHsieh, S. S., Malerczyk, C., Aigner, A. M., & Czubayko, F. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000601)86:5<644::aid-ijc7>3.0.co;2-t · Cited by 37
Self-citationCytotoxicity of the novel anti-cancer drug rViscumin depends on HER-2 levels in SKOV-3 cells
Abuharbeid, S., Apel, J., Sander, M., Fiedler, B., Langer, M., Zuzarte, M., Czubayko, F., & Aigner, A. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.160 · Cited by 32
Self-citation
Cited by
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
New approaches and procedures for cancer treatment: Current perspectives
Debela, D. T., Muzazu, S. G., Heraro, K. D., Ndalama, M. T., Mesele, B. W., Haile, D. C., Kitui, S. K., & Manyazewal, T. (2021) · SAGE Open Medicine · doi:10.1177/20503121211034366 · Cited by 1,597
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Metadata
- Authors
- Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A.
- Venue
- Gene Therapy
- Published
- 2004-12-23
- Volume
- 12
- Issue
- 5
- Pages
- 461-466
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2092049057
- Cited by
- 716
- References
- 31
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.